Wellington Management Group
AKCA

Wellington Management Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Wellington Management Group’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,071,686
Closed -$16.5M – 2177
2019
Q3 		$16.5M Sell
1,071,686
-47,172
-4% -$1M ﹤0.01% 1021
2019
Q2 		$26.2M Buy
1,118,858
+2,357
+0.2% +$58.2K 0.01% 943
2019
Q1 		$31.6M Sell
1,116,501
-1,980
-0.2% -$57.7K 0.01% 880
2018
Q4 		$33.7M Sell
1,118,481
-655,491
-37% -$18.4M 0.01% 838
2018
Q3 		$62.1M Sell
1,773,972
-830,585
-32% -$25.1M 0.01% 737
2018
Q2 		$61.8M Sell
2,604,557
-779,544
-23% -$18.6M 0.01% 723
2018
Q1 		$86.7M Buy
3,384,101
+590,279
+21% +$12.7M 0.02% 617
2017
Q4 		$48.5M Sell
2,793,822
-430,066
-13% -$8.43M 0.01% 780
2017
Q3 		$89.2M Buy
+3,223,888
New +$59.7M 0.02% 577

Other funds holding AKCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Wellington Management Group's AKCA Position: Q4 2019 in Review

Wellington Management Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2019, closing a stake of 1,071,686 shares — an estimated $16.5M sold.

Wellington Management Group first reported a position in AKCA in Q3 2017 and held it in 9 quarters. The position peaked at $89.2M in Q3 2017. 75 funds tracked by Wall St. Rank hold AKCA as of Q4 2019.

  • Wellington Management Group reported no remaining Akcea Therapeutics Inc position as of Q4 2019 after selling out during the quarter.
  • Wellington Management Group sold 1,071,686 Akcea Therapeutics Inc shares in Q4 2019, an estimated $16.5M.
  • Wellington Management Group first reported a position in Akcea Therapeutics Inc in Q3 2017 and held it in 9 quarters.
  • Wellington Management Group's Akcea Therapeutics Inc position peaked at $89.2M in Q3 2017.
  • 75 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2019.

Based on Wellington Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.